Clarient, Inc. at the 2010 OneMedForum
Ron Andrews, CEO of Clarient, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Articles by Guy M. Scrivo
Strategic Medicine at the 2010 OneMedForum
Michael N. Liebman, President and Managing Director of Strategic Medicine, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
TapImmune, Inc. at the 2010 OneMedForum
Denis Corin, President of TapImmune, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Jeff Eliot Margolis CFO of Xintria Pharmaceutical Corporation
Jeff Eliot Margolis, CFO of Xintria Pharmaceutical Corporation, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
BioSante (NASDAQ: BPAX): LibiGel Provides Big Upside Potential
On 9/22/09, BioSante and Cell Genesys (NASDAQ: CEGE) announced that they have determined the final exchange ratio will be 0.1828 in connection with the previously announced merger between the companies.
The Medical Home: Babysitting the Baby Before it’s Born
Israel-based Biopad has developed a device to monitor a baby’s kicking inside the womb, reports Israel21c. The product was developed to help prevent stillbirths, which […]
In Septic Shock: Are We in the Early Stages of a Sepsis Epidemic?
Few people outside the medical profession have even heard of Sepsis, the third most common cause of death for hospitalized patients in the developed world, […]